Navneet - Q4FY12 Result update - Centrum ... - all-mail-archive

Navneet - Q4FY12 Result update - Centrum ... - all-mail-archive



Navneet Publications

Q4FY12 Result update/Estimate change 11 May 2012

Stationary business spurs growth

Navneet Publications (NPL) reported strong results that was better than our

estimates. Revenue was up 27.5% YoY to Rs1.2bn during Q4 driven by strong

growth in the stationery business. This business, which went through a

slowdown in the first half saw revival in order flows from international as well

as domestic markets. Going forward, both the publication business and

stationery segment are likely to deliver strong growth. We have marginally

revised our estimates for both these businesses considering order flow

expectations in the next 2 years. We retain Buy rating on attractive

valuations, high growth visibility and dividend yield.

Results better than expectation during Q4: NPL reported 27.5% growth in

topline to Rs1.2bn, much better than our expectation due to higher growth in

its stationery business. Operating margin also improved compared to Q3 on

better margin in the stationery business. However, the operating margin at

12.2% was lower on YoY basis as the publication business witnessed lower

margin due to higher raw material expenses.

Stationery business picks up in Q4: After a couple of quarters of

underperformance, the stationery segment picked up in Q4. Revenue grew

32.8% YoY to Rs825mn backed by better order flows from India and abroad.

The PBIT margin remained flat at 13.7% YoY. We expect the performance of

the stationery segment to improve in FY13E as the company expects strong

order flow from international markets.

Y/E Mar (Rsmn) Q4FY12 Q4FY11 YoY (%) Q3FY12 QoQ (%) Q4FY12E

Net Sales 1,185 930 27.5 815 45.5 889 33.3

EBITDA 145 115 (6.3) 90 61.2 80 82.1

EBITDA margin (%) 12.2 16.7 (442) bp 11.0 120 bp 9.0 328 bp

Reported PAT 38 79 (52.3) 40 (6.0) 34 11.7

Adjusted PAT 70 79 (11.0) 40 75.3 34 108.2

PAT margin (%) 5.9 8.5 (256)bp 4.9 101bp 3.8 213 bp

Source: Company, Centrum Research

Publication segment registers 15% growth: The publication business

registered 15% YoY growth to Rs338mn on the back of ongoing syllabus

change in Maharashtra and Gujarat states. Operating margin, however,

declined by 400bp to 18.9% YoY on higher raw material expenses. We believe

that this was more due to higher inventory expenses as growth momentum is

going to be strong in FY13E. Historically, Q4 is a weak quarter for the

publication business from margin perspective as the company procures raw

material in this quarter.

Attractive valuations; Reiterate Buy: We continue to like the stock due to

attractive valuations, better sales mix in favor of the publication segment and

improvement in return ratios. We have marginally tweaked our revenue

estimates for FY13E and FY14E to factor in better revenue growth in

publication and stationery segments. Higher sales growth in the publication

business would come from syllabus change in Maharashtra and Gujarat and

order flows from governments. The stationery segment will see revival in

order flows going forward which will drive revenue. We re-iterate Buy rating

on the stock as it gives an upside of 39% with a dividend yield of 2.6% (on

Rs1.4 dividend per share).



Key Data

Recco (Prev) Buy (Buy) Bloomberg Code NPI IN

Target (Prev) Rs75 (Rs75) Reuters Code NAVN.BO

CMP Rs54* Current Shares O/S (mn) 238.2

Upside (%) 39.1% Diluted Shares O/S(mn) 238.2

Mkt Cap (Rsbn/USDmn) 13.1/262.7

Price Performance (%)* 52 Wk H / L (Rs) 71/51

1M 6M 1Yr Daily Vol. (3M NSE Avg.) 289,868

NPL (3.3) (16.0) (0.5) Face Value (Rs) 2

NIFTY (0.6) 3.5 (3.4) USD = Rs53.6

Source: Bloomberg, Centrum Research

*as on 11 May 2012

Stationery business picked up in Q4





















321 825

478 338

Q4FY11 Q1FY12 Q2FY12 Q3FY12 Q4FY12

Publication Stationery Others

Source: Company, Centrum Research

Stationery business pulled the overall margin






















Q4FY11 Q1FY12 Q2FY12 Q3FY12 Q4FY12



Source: Company, Centrum Research

Earning Revision


Publication Stationery Total



Particulars Current Earlier Chg (%) Current Earlier Chg (%)

Revenue 7,203 6,838 5.3 8,321 7,857 5.9

EBITDA 1,725 1,695 1.7 2,076 2,045 1.5

EBITDA margin (%) 23.9 24.8 (-)85 bp 24.9 26.0 (-)108 bp

PAT 1,056 1,009 4.7 1,283 1,227 4.6

PAT margin (%) 14.7 14.7 (-)9 bp 15.4 15.6 (-)20 bp

Source: Company, Centrum Research Estimate

Abhishek Anand

+91 22 4215 9853

Y/E Mar (Rsmn) Rev YoY (%) EBITDA EBITDA (%) Adj PAT YoY (%) Fully DEPS RoE (%) RoCE (%) P/E (x) EV/EBITDA (x)

FY11 5,512 5.2 1,163 21.1 668 4.4 2.8 21.5 18.0 19.3 11.6

FY12E 6,257 13.5 1,423 22.7 827 23.9 3.5 24.0 20.1 15.6 9.7

FY13E 7,203 15.1 1,725 23.9 1,056 27.6 4.4 26.7 22.5 12.2 7.9

FY14E 8,321 15.5 2,076 24.9 1,283 21.5 5.4 27.6 24.6 10.1 6.4

FY15E 8,750 5 2,190 25.0 1,353 5.5 5.7 24.8 22.9 9.5 5.7

Source: Company, Centrum Research Estimates

Please refer to important disclosures/disclaimers inside

Centrum Equity Research is available on Bloomberg, Thomson Reuters and FactSet


Exhibit 1: Income Statement

Y/E March (Rsmn) FY11 FY12E FY13E FY14E FY15E

Net Sales 5,512 6,257 7,203 8,321 8,750

Growth (%) 5.2 13.5 15.1 15.5 5.2

Cost of goods sold 3,032 3,387 3,827 4,363 4,578

% of sales 55.0 54.1 53.1 52.4 52.3

Salary expenses 540 564 639 711 749

% of sales 9.8 9.0 8.9 8.5 8.6

SG&A expenses 776 883 1,013 1,171 1,233

% of sales 14.1 14.1 14.1 14.1 14.1

Operating Profits 1,163 1,423 1,725 2,076 2,190

% of sales 21.1 22.7 23.9 24.9 25.0

Depreciation & Amortisation 136 179 193 225 256

PBIT 1027 1243 1532 1851 1935

Interest Expenses 32 38 40 30 23

PBT from operations 995 1206 1492 1821 1912

Other non operating income 73 75 70 75 80

PBT before extraordinary items 1068 1281 1562 1896 1992

Extraordinary income/(exp.) 33

PBT 1068 1248 1562 1896 1992

PBT margin (%) 19.4 19.9 21.7 22.8 22.8

Provision for tax 404 420 504 609 632

Effective tax rate (%) 37.8 32.8 32.2 32.1 31.7

Minority Interest (3) 1 3 4 7

Net Profit (reported) 668 827 1056 1283 1353

Growth (%) 4.4 23.9 27.6 21.5 5.5

NPM (%) 12.1 13.2 14.7 15.5 15.5

Source: Company, Centrum Research Estimates

Exhibit 2: Balance Sheet

Y/E March (Rsmn) FY11 FY12E FY13E FY14E FY15E

Share Capital 476 476 476 476 476

Reserves and Surplus 2,750 3,188 3,797 4,578 5,430

Total shareholders fund 3,226 3,664 4,274 5,054 5,907

Minority Interest (3) (2) 0 5 12

Loan fund 663 850 735 450 450

Total capital employed 3,920 4,544 5,042 5,542 6,401

Gross block 2,411 2,582 2,877 3,143 3,409

Less: Accumulated dep. 1,222 1,401 1,594 1,819 2,074

Net block 1,189 1,181 1,283 1,324 1,335

Capital WIP 98 160 161 189 160

Investments 1 451 451 451 451

Cash and bank 113 -25 82 87 794

Inventories 1,771 2,180 2,129 2,376 2,460

Debtors 868 1,144 1,135 1,316 1,383

Other current assets & loans

& adv. 409 224 650 752 791

Total current assets 3,161 3,523 3,996 4,530 5,428

Current liabilities and

Provision 530 770 850 953 973

Net current assets 2,631 2,753 3,146 3,578 4,455

Total assets 3,920 4,545 5,042 5,542 6,401

Source: Company, Centrum Research Estimates

Exhibit 3: Cash flow

Y/E March (Rsmn) FY11 FY12E FY13E FY14E FY15E

Cash Flow from operation

Profit before tax 1,068 1,281 1,562 1,896 1,992

Depreciation 136 179 193 225 256

Interest expenses 32 38 40 30 23

Other non cash charges (14) (70) (30) (45) (58)

Op. profit bef. WC change 1,190 1,390 1,725 2,076 2,190

Working capital adjustments (193) (259) (288) (427) (171)

Net cash from operation 601 712 933 1,040 1,388

Cash flow from investing

Capex (412) (233) (295) (294) (237)

Net cash from investment (353) (608) (225) (219) (157)

Cash flow from financing

Borrowings/(Repayments) (46) 187 (115) (285) -

Interest paid (32) (38) (40) (30) (23)

Dividend paid (168) (390) (446) (502) (502)

Net cash flow from financing (246) (241) (601) (816) (524)

Net cash increase/(decrease) 2 (138) 107 5 707

Source: Company, Centrum Research Estimates

Exhibit 4: Key Ratios

Y/E March FY11 FY12E FY13E FY14E FY15E

Margin Ratio (%)

EBITDA Margin 20.7 22.7 23.5 24.5 24.6

PBIT Margin 18.3 19.9 20.9 21.9 21.7

PBT Margin 19.0 20.5 21.3 22.4 22.4

PAT Margin 11.8 13.2 14.4 15.2 15.3

Growth Ratio (%)

Revenue 5.2 13.5 15.1 15.5 5.2

EBITDA 8.8 22.3 21.2 20.4 5.5

Net Profit 4.2 24.6 27.9 21.6 5.7

Return Ratios (%)

ROCE 18.0 20.2 22.6 24.7 23.0

ROIC 31.6 34.0 36.2 39.9 39.6

ROE 21.5 24.0 26.7 27.6 24.8

Turnover Ratios

Asset turnover ratio (x) 1.5 1.5 1.5 1.6 1.5

Working capital cycle (days) 157.8 159.2 148.6 135.2 139.1

Avg. collection period (days) 55.2 58.7 56.7 52.8 55.3

Avg. payment period (days) 13.4 14.7 15.4 14.7 15.4

Per share (Rs)

Basic EPS 2.8 3.5 4.4 5.4 5.7

Fully diluted EPS 2.8 3.5 4.4 5.4 5.7

Book value 13.5 15.4 17.9 21.2 24.8

Solvency Ratio

Debt-equity 0.2 0.2 0.2 0.1 0.1

Interest coverage ratio 32.5 32.9 38.7 62.5 86.0


P/E 19.3 15.6 12.2 10.1 9.5

P/BV 4.0 3.5 3.0 2.6 2.2

EV/Sales 2.4 2.2 1.9 1.6 1.4

M-cap/Sales 2.3 2.1 1.8 1.6 1.5

Source: Company, Centrum Research Estimates


Navneet Publications

Appendix A


Centrum Broking Limited (“Centrum”) is a full-service, Stock Broking Company and a member of The Stock Exchange, Mumbai (BSE) and National Stock Exchange of India Ltd. (NSE). Our

holding company, Centrum Capital Ltd, is an investment banker and an underwriter of securities. As a group Centrum has Investment Banking, Advisory and other business relationships

with a significant percentage of the companies covered by our Research Group. Our research professionals provide important inputs into the Group's Investment Banking and other

business selection processes.

Recipients of this report should assume that our Group is seeking or may seek or will seek Investment Banking, advisory, project finance or other businesses and may receive commission,

brokerage, fees or other compensation from the company or companies that are the subject of this material/report. Our Company and Group companies and their officers, directors and

employees, including the analysts and others involved in the preparation or issuance of this material and their dependants, may on the date of this report or from, time to time have

"long" or "short" positions in, act as principal in, and buy or sell the securities or derivatives thereof of companies mentioned herein. Centrum or its affiliates do not own 1% or more in the

equity of this company Our sales people, dealers, traders and other professionals may provide oral or written market commentary or trading strategies to our clients that reflect opinions

that are contrary to the opinions expressed herein, and our proprietary trading and investing businesses may make investment decisions that are inconsistent with the recommendations

expressed herein. We may have earlier issued or may issue in future reports on the companies covered herein with recommendations/ information inconsistent or different those made in

this report. In reviewing this document, you should be aware that any or all of the foregoing, among other things, may give rise to or potential conflicts of interest. We and our Group

may rely on information barriers, such as "Chinese Walls" to control the flow of information contained in one or more areas within us, or other areas, units, groups or affiliates of Centrum.

Centrum or its affiliates do not make a market in the security of the company for which this report or any report was written. Further, Centrum or its affiliates did not make a market in the

subject company’s securities at the time that the research report was published.

This report is for information purposes only and this document/material should not be construed as an offer to sell or the solicitation of an offer to buy, purchase or subscribe to any

securities, and neither this document nor anything contained herein shall form the basis of or be relied upon in connection with any contract or commitment whatsoever. This document

does not solicit any action based on the material contained herein. It is for the general information of the clients of Centrum. Though disseminated to clients simultaneously, not all clients

may receive this report at the same time. Centrum will not treat recipients as clients by virtue of their receiving this report. It does not constitute a personal recommendation or take into

account the particular investment objectives, financial situations, or needs of individual clients. Similarly, this document does not have regard to the specific investment objectives,

financial situation/circumstances and the particular needs of any specific person who may receive this document. The securities discussed in this report may not be suitable for all

investors. The securities described herein may not be eligible for sale in all jurisdictions or to all categories of investors. The countries in which the companies mentioned in this report are

organized may have restrictions on investments, voting rights or dealings in securities by nationals of other countries. The appropriateness of a particular investment or strategy will

depend on an investor's individual circumstances and objectives. Persons who may receive this document should consider and independently evaluate whether it is suitable for his/

her/their particular circumstances and, if necessary, seek professional/financial advice. Any such person shall be responsible for conducting his/her/their own investigation and analysis of

the information contained or referred to in this document and of evaluating the merits and risks involved in the securities forming the subject matter of this document.

The projections and forecasts described in this report were based upon a number of estimates and assumptions and are inherently subject to significant uncertainties and contingencies.

Projections and forecasts are necessarily speculative in nature, and it can be expected that one or more of the estimates on which the projections and forecasts were based will not

materialize or will vary significantly from actual results, and such variances will likely increase over time. All projections and forecasts described in this report have been prepared solely by

the authors of this report independently of the Company. These projections and forecasts were not prepared with a view toward compliance with published guidelines or generally

accented accounting principles. No independent accountants have expressed an opinion or any other form of assurance on these projections or forecasts. You should not regard the

inclusion of the projections and forecasts described herein as a representation or warranty by or on behalf of the Company, Centrum, the authors of this report or any other person that

these projections or forecasts or their underlying assumptions will be achieved. For these reasons, you should only consider the projections and forecasts described in this report after

carefully evaluating all of the information in this report, including the assumptions underlying such projections and forecasts.

The price and value of the investments referred to in this document/material and the income from them may go down as well as up, and investors may realize losses on any investments.

Past performance is not a guide for future performance. Future returns are not guaranteed and a loss of original capital may occur. Actual results may differ materially from those set forth

in projections. Forward-looking statements are not predictions and may be subject to change without notice. Centrum does not provide tax advice to its clients, and all investors are

strongly advised to consult regarding any potential investment. Centrum and its affiliates accept no liabilities for any loss or damage of any kind arising out of the use of this report.

Foreign currencies denominated securities are subject to fluctuations in exchange rates that could have an adverse effect on the value or price of or income derived from the investment.

In addition, investors in securities such as ADRs, the value of which are influenced by foreign currencies effectively assume currency risk. Certain transactions including those involving

futures, options, and other derivatives as well as non-investment-grade securities give rise to substantial risk and are not suitable for all investors. Please ensure that you have read and

understood the current risk disclosure documents before entering into any derivative transactions.

This report/document has been prepared by Centrum, based upon information available to the public and sources, believed to be reliable. No representation or warranty, express or

implied is made that it is accurate or complete. Centrum has reviewed the report and, in so far as it includes current or historical information, it is believed to be reliable, although its

accuracy and completeness cannot be guaranteed. The opinions expressed in this document/material are subject to change without notice and have no obligation to tell you when

opinions or information in this report change.

This report or recommendations or information contained herein do/does not constitute or purport to constitute investment advice in publicly accessible media and should not be

reproduced, transmitted or published by the recipient. The report is for the use and consumption of the recipient only. This publication may not be distributed to the public used by the

public media without the express written consent of Centrum. This report or any portion hereof may not be printed, sold or distributed without the written consent of Centrum.

This report has not been prepared by Centrum Securities LLC. However, Centrum Securities LLC has reviewed the report and, in so far as it includes current or historical information, it is

believed to be reliable, although its accuracy and completeness cannot be guaranteed.

The distribution of this document in other jurisdictions may be restricted by law, and persons into whose possession this document comes should inform themselves about, and observe,

any such restrictions. Neither Centrum nor its directors, employees, agents or representatives shall be liable for any damages whether direct or indirect, incidental, special or

consequential including lost revenue or lost profits that may arise from or in connection with the use of the information.

This document does not constitute an offer or invitation to subscribe for or purchase or deal in any securities and neither this document nor anything contained herein shall form the

basis of any contract or commitment whatsoever. This document is strictly confidential and is being furnished to you solely for your information, may not be distributed to the press or

other media and may not be reproduced or redistributed to any other person. The distribution of this report in other jurisdictions may be restricted by law and persons into whose

possession this report comes should inform themselves about, and observe any such restrictions. By accepting this report, you agree to be bound by the fore going limitations. No

representation is made that this report is accurate or complete.

The opinions and projections expressed herein are entirely those of the author and are given as part of the normal research activity of Centrum Broking and are given as of this date and

are subject to change without notice. Any opinion estimate or projection herein constitutes a view as of the date of this report and there can be no assurance that future results or events

will be consistent with any such opinions, estimate or projection.

This document has not been prepared by or in conjunction with or on behalf of or at the instigation of, or by arrangement with the company or any of its directors or any other person.

Information in this document must not be relied upon as having been authorized or approved by the company or its directors or any other person. Any opinions and projections

contained herein are entirely those of the authors. None of the company or its directors or any other person accepts any liability whatsoever for any loss arising from any use of this

document or its contents or otherwise arising in connection therewith.

Centrum and its affiliates have not managed or co-managed a public offering for the subject company in the preceding twelve months. Centrum and affiliates have not received

compensation from the companies mentioned in the report during the period preceding twelve months from the date of this report for service in respect of public offerings, corporate

finance, debt restructuring, investment banking or other advisory services in a merger/acquisition or some other sort of specific transaction.

As per the declarations given by them, Mr Abhishek Anand, research analyst and the authors of this report and/or any of their family members do not serve as an officer, director or any

way connected to the company/companies mentioned in this report. Further, as declared by them, they have not received any compensation from the above companies in the preceding

twelve months. Our entire research professionals are our employees and are paid a salary. They do not have any other material conflict of interest of the research analyst or member of

which the research analyst knows of has reason to know at the time of publication of the research report or at the time of the public appearance.

While we would endeavor to update the information herein on a reasonable basis, Centrum, its associated companies, their directors and employees are under no obligation to update or

keep the information current. Also, there may be regulatory, compliance or other reasons that may prevent Centrum from doing so.

Non-rated securities indicate that rating on a particular security has been suspended temporarily and such suspension is in compliance with applicable regulations and/or Centrum

policies, in circumstances where Centrum is acting in an advisory capacity to this company, or any certain other circumstances

Key to Centrum Investment Rankings

Buy: Expected outperform Nifty by>15%, Accumulate: Expected to outperform Nifty by +5 to 15%, Hold: Expected to outperform Nifty by -5% to +5%, Reduce: Expected to underperform

Nifty by 5 to 15%, Sell: Expected to underperform Nifty by>15%


Navneet Publications

Centrum Broking Limited

Member (NSE, BSE, MCX-SX), Depository Participant (CDSL) and SEBI registered Portfolio Manager

Registration Nos.





MCX – SX (Currency Derivative segment) REGN. NO.: INE261454236


Investor Grievance Email ID:

Compliance Officer Details :

Mr. Praveen Malik; Tel: (022) 42159703; Email ID:

Registered Office Address

Bombay Mutual Building ,2nd Floor,

Dr. D. N. Road, Fort,

Mumbai - 400 001

Correspondence Address

Centrum House

6th Floor, CST Road,

Near Vidya Nagari Marg, Kalina,

Santacruz (E), Mumbai 400 098.

Tel: (022) 4215 9000


Navneet Publications

More magazines by this user
Similar magazines